Alzheimer's disease and mild cognitive impairment are associated with elevated levels of isoaspartyl residues in blood plasma proteins

Journal of Alzheimer's Disease

Volumn 27, Issue 1, 2011, Pages 113-118

  Yang, Hongqian ^a   Lyutvinskiy, Yaroslav ^a   Soininen, Hilkka ^c   Zubarev, Roman A ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b SCIENCE FOR LIFE LABORATORY   (Sweden)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Aspartyl isomerization; blood plasma; electron capture dissociation; label free quantification; tandem mass spectrometry

Indexed keywords

ASPARTIC ACID; ISOASPARTYL RESIDUE; PLASMA PROTEIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DISEASE ASSOCIATION; ELECTRON TRANSPORT; FEMALE; FRAGMENTATION REACTION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TANDEM MASS SPECTROMETRY;

EID: 80155190078     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2011-110626     Document Type: Article

References (40)

1. Johnson BA,Murray ED, Jr, Clarke S, Glass DB, Aswad DW (1987) Protein carboxyl methyltransferase facilitates conversion of atypical L-isoaspartyl peptides to normal L-aspartyl peptides. J Biol Chem 262, 5622-5629.
2. Shimizu T, Fukuda H, Murayama S, Izumiyama N, Shirasawa T (2002) Isoaspartate formation at position 23 of amyloid beta peptide enhanced fibril formation and deposited onto senile plaques and vascular amyloids in Alzheimer's disease. J Neurosci Res 70, 451-461. (Pubitemid 35222382)
3. Yang ML, Doyle HA, Gee RJ, Lowenson JD, Clarke S, Lawson BR, Aswad DW, Mamula MJ (2006) Intracellular protein modification associated with altered T cell functions in autoimmunity. J Immunol 177, 4541-4549. (Pubitemid 44469785)
4. Deverman BE, Cook BL, Manson SR, Niederhoff RA, Langer EM, Rosov I, Kulans LA, Fu X, Weinberg JS, Heinecke JW, Roth KA, Weintraub SJ (2002) Bcl-xL deamidation is a critical switch in the regulation of the response to DNA damage. Cell 111, 51-62.
5. Vlasak J, Bussat MC,Wang SY,Wagner-Rousset E, Schaefer M, Klinguer-Hamour C, Kirchmeier M, Corvaia N, Ionescu R, Beck A (2009) Identification and characterization of asparagine deamidation in the light chain CDR1 of a humanized IgG1 antibody. Anal Biochem 392, 145-154.
6. O'Connor CM (2006) Protein L-isoaspartyl, D-aspartyl Omethyltransferases: Catalysts for protein repair. In The Enzymes, Tamanoi F, Clarke S, eds., Academic Press, vol. 24, pp. 385-433.
7. Khare S, Gomez T, Linster CL, Clarke SG (2009) Defective responses to oxidative stress in protein L-isoaspartyl repairdeficient Caenorhabditis elegans. Mech Ageing Dev 130, 670-680.
8. Shimizu T, Ikegami T, Ogawara M, Suzuki Y-i, Takahashi M, Morio H, Shirasawa T (2002) Transgenic expression of the protein-L-isoaspartyl methyltransferase (PIMT) gene in the brain rescues mice from the fatal epilepsy of PIMT deficiency. J Neurosci Res 69, 341-352. (Pubitemid 34809483)
9. Yamamoto A, Takagi H, Kitamura D, Tatsuoka H, Nakano H, Kawano H, Kuroyanagi H, Yahagi Y-i, Kobayashi S-i, Koizumi K-i, Sakai T, Saito K-i, Chiba T, Kawamura K, Suzuki K, Watanabe T, Mori H, Shirasawa T (1998) Deficiency in protein L-isoaspartyl methyltransferase results in a fatal progressive epilepsy. J Neurosci 18, 2063-2074. (Pubitemid 28141413)
10. Kim E, Lowenson JD, MacLaren DC, Clarke S, Young SG (1997) Deficiency of a protein-repair enzyme results in the accumulation of altered proteins, retardation of growth, and fatal seizures in mice. Proc Natl Acad SciUSA94, 6132-6137. (Pubitemid 27270649)
11. Reissner KJ,AswadDW(2003) Deamidation and isoaspartate formation in proteins: unwanted alterations or surreptitious signals? Cell Mol Life Sci 60, 1281-1295. (Pubitemid 36900513)
12. Shimizu T, Matsuoka Y, Shirasawa T (2005) Biological significance of isoaspartate and its repair system. Biol Pharm Bull 28, 1590-1596. (Pubitemid 41324114)
13. Shimizu T, Watanabe A, Ogawara M, Mori H, Shirasawa T (2000) Isoaspartate formation and neurodegeneration in Alzheimer's disease. Arch Biochem Biophys 381, 225-234. (Pubitemid 32260308)
14. Perna AF, Castaldo P, De Santo NG, Di Carlo E, Cimmino A, Galletti P, Zappia V, Ingrosso D (2001) Plasma proteins containing damaged L-isoaspartyl residues are increased in uremia: Implications for mechanism. Kidney Int 59, 2299-2308. (Pubitemid 32467624)
15. Hasegawa T, Ichiba M, Tabira T (2011) Pathogenesis of AD is similar to that of uremic encephalopathy of homocysteic acid. Nature Precedings. http://hdl.handle.net/10101/npre.2011.5833.1.
16. Cummings JL,VintersHV, ColeGM,KhachaturianZS(1998) Alzheimer's disease-etiologies, pathophysiology, cognitive reserve, and treatment opportunities. J Neurol 51, S2-S17. (Pubitemid 28345337)
17. Schmidt R, Assem-Hilger E, Benke T, Dal-Bianco P, Delazer M, Ladurner G, Jellinger K, Marksteiner J, Ransmayr G, Schmidt H, Stogmann E, Wancata J, Wehringer C (2008) Sex differences in Alzheimer disease. Neuropsychiatrie 22, 1-15. (Pubitemid 351684887)
18. Plassman BL, LangaKM, Fisher GG, Heeringa SG,Weir DR, Ofstedal MB, Burke JR, Hurd MD, Potter GG, Rodgers WL, Steffens DC, Willis RJ, Wallace RB (2007) Prevalence of dementia in the united states: The aging, demographics, and memory study. Neuroepidemiology 29, 125-132. (Pubitemid 350191430)
19. Hui JO, Chow DT, Markell D, Robinson JH, Katta V, Nixon L, Chang BS, Rohde MF, Haniu M (1998) Identification of Asp(95) as the site of succinimide formation in recombinant human glial cell line-derived neurotrophic factor. Arch Biochem Biophys 358, 377-384. (Pubitemid 28480958)
20. Johnson BA, Aswad DW (1991) Optimal conditions for the use of protein-isoaspartyl methyltransferase in assessing the isoaspartate content of peptides and proteins. Anal Biochem 192, 384-391.
21. Yang H, Zubarev RA (2010) Mass spectrometric analysis of asparagine deamidation and aspartate isomerization in polypeptides. Electrophoresis 31, 1764-1772.
22. Cournoyer JJ, O'Connor PB (2008) Chapter 16 Analysis of Deamidation in Proteins. In Comprehensive Analytical Chemistry, Julian PW, ed., Elsevier pp. 375-410.
23. Zubarev RA, Kelleher NL, McLafferty FW (1998) Electron capture dissociation of multiply charged protein cations. A nonergodic process. J Am Chem Soc 120, 3265-3266.
24. Syka JEP, Coon JJ, Schroeder MJ, Shabanowitz J, Hunt DF (2004) Peptide and protein sequence analysis by electron transfer dissociation mass spectrometry. Proc Natl Acad Sci USA 101, 9528-9533. (Pubitemid 38869270)
25. Cournoyer JJ, Pittman JL, Ivleva VB, Fallows E, Waskell L, Costello CE, O'Connor PB (2005) Deamidation: differentiation of aspartyl from isoaspartyl products in peptides by electron capture dissociation. Prot Sci 14, 452-463. (Pubitemid 40194598)
26. ChanW, Chan T, O'Connor P (2010) Electron transfer dissociation with supplemental activation to differentiate aspartic and isoaspartic residues in doubly charged peptide cations. J Am Soc Mass Spectrom 21, 1012-1015.
27. Yang H, FungEYM,Zubarev AR, ZubarevRA(2009)Toward proteome-scale identification and quantification of isoaspartyl residues in biological samples. J Proteome Res 8, 4615-4621.
28. Krokhin OV, Antonovici M, EnsW,Wilkins JA, Standing KG (2006) Deamidation of-Asn-Gly-sequences during sample preparation for proteomics: consequences for MALDI and HPLC-MALDI analysis. Anal Chem 78, 6645-6650. (Pubitemid 44413621)
29. Clarke S (1987) Propensity for spontaneous succinimide formation from aspartyl and asparaginyl residues in cellular proteins. Int J Pept Protein Res 30, 808-821.
30. Julkunen V, Niskanen E, Koikkalainen J, Herukka SK, Pihlajamaki M, Hallikainen M, Kivipelto M, Muehlboeck S, Evans AC, Vanninen R, Soininen H (2010) Differences in cortical thickness in healthy controls, subjects with mild cognitive impairment, and Alzheimer's disease patients: a longitudinal study. J Alzheimers Dis 21, 1141-1151.
31. Lundgren DH, Hwang SI, Wu LF, Han DK (2010) Role of spectral counting in quantitative proteomics. Expert Rev Proteomics 7, 39-53.
32. Alves T, Ferreira LK, Wajngarten M, Busatto GF (2010) Cardiac disorders as risk factors for Alzheimer's disease. J Alzheimers Dis 20, 749-763.
33. Melnyk S, Pogribna M, Pogribny IP, Yi P, James SJ (2000) Measurement of plasma and intracellular S-adenosylmethionine and S-adenosylhomocysteine utilizing coulometric electrochemical detection: Alterations with plasma homocysteine and pyridoxal 5β-phosphate concentrations. Clin Chem 46, 265-272. (Pubitemid 30104251)
34. Boivin D, Gingras D, B́eliveau R (1993) Purification and characterization of a membrane-bound protein carboxyl methyltransferase from rat kidney cortex. J Biol Chem 268, 2610-2615. (Pubitemid 23057886)
35. Weber DJ, McFadden PN (1997) Detection and characterization of a protein isoaspartyl methyltransferase which becomes trapped in the extracellular space during blood vessel injury. J Protein Chem 16, 257-267. (Pubitemid 27242350)
36. Poirier LA, Wise CK, Delongchamp RR, Sinha R (2001) Blood determinations of S-adenosylmethionine, S-adenosylhomocysteine, and homocysteine. Cancer Epidemiol Biomarkers Prev 10, 649-655. (Pubitemid 32703199)
37. Pepperkok R, Hotz-Wagenblatt A, Konig N, Girod A, Bossemeyer D, Kinzel V (2000) Intracellular distribution of mammalian protein kinase a catalytic subunit altered by conserved Asn2 deamidation. J Cell Biol 148, 715-726.
38. Curnis F, Cattaneo A, Longhi R, Sacchi A, Gasparri AM, Pastorino F, Di Matteo P, Traversari C, Bachi A, Ponzoni M, Rizzardi GP, Corti A (2010) Critical role of flanking residues in NGR-to-isoDGR transition and CD13/integrin receptor switching. J Biol Chem 285, 9114-9123.
39. Rehder DS, Chelius D, McAuley A, Dillon TM, Xiao G, Crouse-Zeineddini J, Vardanyan L, Perico N, Mukku V, Brems DN, Matsumura M, Bondarenko PV (2008) Isomerization of a single aspartyl residue of anti-epidermal growth factor receptor immunoglobulin gamma2 antibody highlights the role avidity plays in antibody activity. Biochem 47, 2518-2530. (Pubitemid 351304557)
40. Orpiszewski J, Schormann N, Kluve-Beckerman B, Liepnieks JJ, BensonMD(2000) Protein aging hypothesis of Alzheimer disease. FASEB J 14, 1255-1263. (Pubitemid 30350407)